SCHEMBL11034753

SCHEMBL11034753

O=C1Nc2ccccc2SC1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.61
KDM4E B2RXH2 3/20 0.61
TDP1 Q9NUW8 3/20 0.61
POLB P06746 2/20 0.61
ALOX15 P16050 2/20 0.61
USP2 O75604 1/20 0.61
ESR1 P03372 1/20 0.61
THRB P10828 1/20 0.61
HPGD P15428 1/20 0.61
PTPN7 P35236 1/20 0.61
RECQL P46063 1/20 0.61
ESR2 Q92731 1/20 0.61
CTDSP1 Q9GZU7 1/20 0.61
GLA P06280 1/20 0.57
HTT P42858 2/20 0.51
MAPT P10636 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
TSHR P16473 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28768922 0.77 HSD17B10 (0.53) HSD17B10KDM4ETDP1POLBALOX15
SCHEMBL2745305 0.77 CREBBP (0.57) HSD17B10KDM4ETDP1POLBALOX15
SCHEMBL4325934 0.77 HSD17B10 (0.53) HSD17B10KDM4ETDP1POLBALOX15
SCHEMBL9024189 0.77 HSD17B10 (0.53) HSD17B10KDM4ETDP1POLBALOX15
SCHEMBL31542005 0.77 HSD17B10 (0.53) HSD17B10KDM4ETDP1POLBALOX15
SCHEMBL24125191 0.77 CREBBP (0.57) HSD17B10KDM4ETDP1POLBALOX15
SCHEMBL10735538 0.77 HSD17B10 (0.69) HSD17B10KDM4ETDP1POLBALOX15
SCHEMBL8477667 0.76 HSD17B10 (1.00) HSD17B10KDM4ETDP1POLBALOX15
SCHEMBL8477662 0.76 HSD17B10 (1.00) HSD17B10KDM4ETDP1POLBALOX15
SCHEMBL2117385 0.76 HSD17B10 (1.00) HSD17B10KDM4ETDP1POLBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4535079-A HYPOTENSIVE, ANTIARRHYTHMIA, ADRENERGIC BLOCKING AGENTS; VASODILATORS MEDIOLANUM FARMACEUTICI S.R.L. (IT) 1985-08-13 US disclosed
EP-0106816-A2 Alkanolaminoxy derivatives of 3,4-dihydro-2H-1,4-benzothiazin-3-one, their production process, and their pharmaceutical use MEDIOLANUM FARMACEUTICI s.r.l. (IT) 1984-04-25 EP disclosed